MoneyWorks4Me

Sanofi India - Quaterly Results

26 Jul 2024 Evaluate
A decrease in the sales to Rs. 4635.00 millions was observed for the quarter ended June 2024. The sales stood at Rs. 5149.00 millions during the similar quarter previous year.Net profit declined -15.80% to Rs. 682.00 millions from Rs. 810.00 millions.Operating profit for the quarter ended June 2024 decreased to 1205.00 millions as compared to 1371.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202312 202212 % Var
Sales 4635.00 5149.00 -9.98 11959.00 12514.00 -4.44 28511.00 27701.00 2.92
Other Income 48.00 155.00 -69.03 113.00 413.00 -72.64 653.00 715.00 -8.67
PBIDT 1205.00 1371.00 -12.11 3459.00 3928.00 -11.94 8693.00 7759.00 12.04
Interest 4.00 7.00 -42.86 7.00 10.00 -30.00 17.00 17.00 0.00
PBDT 1011.00 1364.00 -25.88 2995.00 4096.00 -26.88 8854.00 9062.00 -2.30
Depreciation 90.00 91.00 -1.10 190.00 188.00 1.06 396.00 419.00 -5.49
PBT 921.00 1273.00 -27.65 2805.00 3908.00 -28.22 8458.00 8643.00 -2.14
TAX 239.00 463.00 -48.38 757.00 1194.00 -36.60 2426.00 2437.00 -0.45
Deferred Tax -33.00 -8.00 312.50 -115.00 -15.00 666.67 -7.00 -15.00 -53.33
PAT 682.00 810.00 -15.80 2048.00 2714.00 -24.54 6032.00 6206.00 -2.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 26.00 26.63 -2.36 28.92 31.39 -7.85 30.49 28.01 8.85
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..